About

Access Vascular is developing a platform of venous access devices using our novel bulk hydrophilic biomaterial technology which inhibits the accumulation of blood components otherwise known as thrombus. . The HydroPICCâ„¢ is the first in our suite of venous access devices and studies show a significant reduction in platelet count with the HydroPICC versus current devices.